Peptide ligands for pro-survival protein Bfl-1 from computationally guided library screening.
暂无分享,去创建一个
Amy E Keating | A. Keating | Sanjib Dutta | T Scott Chen | Sanjib Dutta | Keating | Peptide | T. S. Chen | Citation Dutta | T. S. Sanjib | Amy E Chen
[1] Eric T. Boder,et al. Yeast surface display for screening combinatorial polypeptide libraries , 1997, Nature Biotechnology.
[2] Liisa Holm,et al. Dali server: conservation mapping in 3D , 2010, Nucleic Acids Res..
[3] S. Tait,et al. Bcl-2 Family Member Bfl-1/A1 Sequesters Truncated Bid to Inhibit Its Collaboration with Pro-apoptotic Bak or Bax* , 2002, The Journal of Biological Chemistry.
[4] P. Marrack,et al. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. , 2003, Immunity.
[5] Amy E Keating,et al. Predictive Bcl-2 family binding models rooted in experiment or structure. , 2012, Journal of molecular biology.
[6] Erinna F. Lee,et al. High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. , 2009, Angewandte Chemie.
[7] J. Richardson,et al. The penultimate rotamer library , 2000, Proteins.
[8] Z. Ling,et al. Genomic-wide analysis of lymphatic metastasis-associated genes in human hepatocellular carcinoma. , 2009, World journal of gastroenterology.
[9] S. Richardson,et al. Solution Structure of Prosurvival Mcl-1 and Characterization of Its Binding by Proapoptotic BH3-only Ligands* , 2005, Journal of Biological Chemistry.
[10] H. Varmus,et al. MYC-induced myeloid leukemogenesis is accelerated by all six members of the antiapoptotic BCL family , 2009, Oncogene.
[11] Gerhard Wagner,et al. A general framework for development and data analysis of competitive high-throughput screens for small-molecule inhibitors of protein-protein interactions by fluorescence polarization. , 2004, Biochemistry.
[12] Emiko Fire,et al. Mcl‐1–Bim complexes accommodate surprising point mutations via minor structural changes , 2010, Protein science : a publication of the Protein Society.
[13] W. Zong,et al. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist , 2008, Oncogene.
[14] M. Berger,et al. Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2. , 1993, Journal of immunology.
[15] R. Rosenquist,et al. Upregulation of bfl-1 is a potential mechanism of chemoresistance in B-cell chronic lymphocytic leukaemia , 2007, British Journal of Cancer.
[16] S. Eschrich,et al. The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis , 2008, BMC Medical Genomics.
[17] Nir London,et al. In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2. , 2012, Biochemistry.
[18] S. Armstrong,et al. Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.
[19] Brian J. Smith,et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.
[20] Suzanne Cory,et al. The Bcl-2 family: roles in cell survival and oncogenesis , 2003, Oncogene.
[21] K Dane Wittrup,et al. Isolating and engineering human antibodies using yeast surface display , 2006, Nature Protocols.
[22] K. Rajewsky,et al. Efficiency of RNA Interference in the Mouse Hematopoietic System Varies between Cell Types and Developmental Stages , 2005, Molecular and Cellular Biology.
[23] C. Berking,et al. Selective Induction of Cell Death in Melanoma Cell Lines through Targeting of Mcl-1 and A1 , 2012, PloS one.
[24] M. Vogler,et al. BCL2A1: the underdog in the BCL2 family , 2011, Cell Death and Differentiation.
[25] Pär Nordlund,et al. Completing the family portrait of the anti‐apoptotic Bcl‐2 proteins: Crystal structure of human Bfl‐1 in complex with Bim , 2008, FEBS letters.
[26] Roberto Piva,et al. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes. , 2006, The Journal of clinical investigation.
[27] A. Keating,et al. Determinants of BH3 binding specificity for Mcl-1 versus Bcl-xL. , 2010, Journal of molecular biology.
[28] C. Raymond,et al. General method for plasmid construction using homologous recombination. , 1999, BioTechniques.
[29] Chengyu Liang,et al. Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.
[30] M. Bickle,et al. Characterization of peptide aptamers targeting Bfl-1 anti-apoptotic protein. , 2011, Biochemistry.
[31] I. Brooks,et al. Determination of rate and equilibrium binding constants for macromolecular interactions using surface plasmon resonance: use of nonlinear least squares analysis methods. , 1993, Analytical biochemistry.
[32] Lin Chen,et al. Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.
[33] S. Korsmeyer,et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.
[34] M. Hinds,et al. Structural plasticity underpins promiscuous binding of the prosurvival protein A1. , 2008, Structure.
[35] A. Strasser,et al. BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death , 2000, Cell.
[36] C. Reynolds,et al. Bcl-2 Inhibitors: Targeting Mitochondrial Apoptotic Pathways in Cancer Therapy , 2009, Clinical Cancer Research.
[37] C. Tse,et al. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor. , 2008, Cancer research.
[38] Catherine Charbonnel,et al. Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen , 2008, Breast Cancer Research and Treatment.
[39] Paul H. C. Eilers,et al. Enhancing scatterplots with smoothed densities , 2004, Bioinform..
[40] David W. Andrews,et al. Embedded together: The life and death consequences of interaction of the Bcl-2 family with membranes , 2007, Apoptosis.
[41] M. Lackmann,et al. The structure of Bcl‐w reveals a role for the C‐terminal residues in modulating biological activity , 2003, The EMBO journal.
[42] Patrick R. Cushing,et al. The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling. , 2008, Biochemistry.
[43] K Dane Wittrup,et al. Yeast surface display for protein engineering and characterization , 2007, Current Opinion in Structural Biology.
[44] J C Reed,et al. Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins , 2006, Cell Death and Differentiation.
[45] Derek Y. Chiang,et al. The landscape of somatic copy-number alteration across human cancers , 2010, Nature.
[46] John Calvin Reed,et al. Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1* , 2008, Journal of Biological Chemistry.
[47] R. Copeland,et al. Residence time of receptor-ligand complexes and its effect on biological function. , 2008, Biochemistry.
[48] A. Keating,et al. Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L). , 2013, Journal of molecular biology.